Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1997 1
1999 3
2001 1
2002 1
2003 1
2005 5
2006 5
2007 2
2008 3
2009 5
2010 3
2011 8
2012 5
2013 5
2014 10
2015 7
2016 3
2018 2
2019 3
2020 2
2021 1
2022 1
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
The IRONy in Athletic Performance.
Kardasis W, Naquin ER, Garg R, Arun T, Gopianand JS, Karmakar E, Gnana-Prakasam JP. Kardasis W, et al. Among authors: arun t. Nutrients. 2023 Nov 28;15(23):4945. doi: 10.3390/nu15234945. Nutrients. 2023. PMID: 38068803 Free PMC article. Review.
A review on applications of chitosan-based Schiff bases.
Antony R, Arun T, Manickam STD. Antony R, et al. Among authors: arun t. Int J Biol Macromol. 2019 May 15;129:615-633. doi: 10.1016/j.ijbiomac.2019.02.047. Epub 2019 Feb 10. Int J Biol Macromol. 2019. PMID: 30753877 Review.
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, Wright S, Shatila M, Yiannakas MC, Chowdhury F, Stutters J, Ricciardi A, Prados F, MacManus D, Braisher M, Blackstone J, Ciccarelli O, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; UCL MS-STAT2 investigators. Williams T, et al. Eur J Neurol. 2023 Sep;30(9):2769-2780. doi: 10.1111/ene.15924. Epub 2023 Jun 23. Eur J Neurol. 2023. PMID: 37318885 Clinical Trial.
Influence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease‑modifying therapies in multiple sclerosis.
Seifer G, Arun T, Capela C, Laureys G, Jones E, Dominguez-Castro P, Sanchez-de la Rosa R, Hiltl S, Iaffaldano P. Seifer G, et al. Among authors: arun t. Mult Scler Relat Disord. 2023 Aug;76:104770. doi: 10.1016/j.msard.2023.104770. Epub 2023 May 26. Mult Scler Relat Disord. 2023. PMID: 37307690 Free article.
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis.
Armoiry X, Wang-Steverding X, Connock M, Grove A, Clarke A, Arun T, Counsell C, Auguste P. Armoiry X, et al. Among authors: arun t. Int J Technol Assess Health Care. 2022 Dec 13;38(1):e83. doi: 10.1017/S0266462322003269. Int J Technol Assess Health Care. 2022. PMID: 36510406 Review.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N, Ford HL, Galea I, George S, Gray OM, Hibbert AM, Hu M, Hughes SE, Ingram G, Kalra S, Lim CE, Mathews JTM, McDonnell GV, Mescall N, Norris S, Ramsay SJ, Rice CM, Russell MJ, Shawe-Taylor MJ, Williams TE, Harding KE, Robertson NP. Tallantyre EC, et al. Among authors: arun t. Eur J Neurol. 2024 Apr 3:e16289. doi: 10.1111/ene.16289. Online ahead of print. Eur J Neurol. 2024. PMID: 38567516
Authors' response.
Nur Yilmaz RB, Germeç Çakan D, Arun T. Nur Yilmaz RB, et al. Among authors: arun t. Am J Orthod Dentofacial Orthop. 2016 Dec;150(6):910-911. doi: 10.1016/j.ajodo.2016.08.015. Am J Orthod Dentofacial Orthop. 2016. PMID: 27894535 No abstract available.
81 results